Peptides — Cosmetic Actives, APIs & Research-Grade
Bioactive cosmetic peptides, GLP-1/metabolic peptide APIs, and research-grade raw powders sourced from ICH-aligned manufacturers across Shanghai, Jiangsu, Xi'an, and Chengdu clusters (incl. tier-1 cGMP houses with 100,000+ sqm capacity). Synthesis market USD 6.18B (2025) → 9.91B (2030). Full CoA (HPLC/LC-MS), cold-chain logistics, HS-code export compliance.

🧴 Lane 1 — Cosmetic & Dermatological Actives
- Anti-wrinkle signal peptides: Palmitoyl Tripeptide-1/-3, Palmitoyl Pentapeptide-4, Acetyl Hexapeptide-8 — 98%+ lyophilised
- Hair regrowth & skin repair: Copper Tripeptide-1 (GHK-Cu), 99% HPLC pure — blue raw powder or 1% aqueous/HA pre-diluted solutions
- Brightening & repair: Oligopeptide-1/-2/-6, Carnosine (anti-glycation), L-Glutathione reduced (GSH), Nonapeptide-1 (melanin modulation), hydrolysed Silk Peptides
- Driven by a 10.2% global CAGR — cosmetic bioactive actives are one of the fastest-growing ingredient sub-categories in skincare
🧪 Lane 2 — Therapeutic / Metabolic APIs & Research-Grade
- GLP-1 & metabolic boom: Semaglutide, Tirzepatide, Retatrutide — post-2026 patent expiry generic SPPS supply from manufacturers with non-infringing process patents
- Standard research SKUs: CJC-1295 no DAC + Ipamorelin blend, CJC-1295 DAC, Hexarelin, GHRP-2/-6, MK-677, BPC-157, TB-500, Melanotan II, PT-141, HGH 176–191, Epitalon, TA-1, MOTS-C, Selank, Semax, DSIP, Pinealon
- Framed as raw materials for licensed compounding pharmacies, R&D institutions, formulation chemists, and authorised importers (not DTC therapeutic claims)
- USD 21.4B global peptide market (2022) at 10.2% CAGR → fueled by GLP-1 & personalised medicine boom
China Manufacturing Advantage
China is the fastest-growing global peptide hub — 60%+ of the world's research peptide volume is synthesised in Shanghai, Guangzhou, Chengdu, and Xi'an clusters. Both SPPS (Solid-Phase Peptide Synthesis) and FPPS (Fluid-Phase) lines exist at scale, enabling seamless transition from milligram R&D samples to multi-kilogram commercial batches. Leading houses now align with ICH guidelines and carry NMPA + international GMP, matching export requirements.
Quality & GMP Standards
ISO 9001 + ISO 22716 Cosmetic GMP + ICH-aligned partners with in-house HPLC, LC-MS/QToF, amino acid analyser, NMR, USP <61>/<62> microbial labs. Every lot ships with traceable CoA covering purity (HPLC area-% corrected), identity (MS MW confirmation ±0.2 Da), moisture (KF), residual TFA/solvents (ICH Q3C), acetate counter-ion, pH, heavy metals Pb/As/Cd/Hg, bioburden USP <61>, endotoxin LAL <0.25 EU/mg (research/injectable grade).
Sinorce Export Commitments & No MOQ Terms
- Rigorous vendor vetting: GMP + ISO + 3rd-lab verification dossier on every shortlisted manufacturer
- Transparent documentation: batch-specific independent-lab CoA, MSDS (16-section GHS), full traceability (raw amino acid → SPPS run → purification → shipment)
- HS-code classification & export compliance navigation + cold-chain logistics: dry-ice/gel-pack thermal packing with data loggers
- No MOQ: 50g–1kg pilots for formulation R&D; tonne-level commercial at identical QC standards
- Standard SKUs: 2–4 weeks; custom SPPS sequences (biotinylation, phosphorylation, PEG, disulfide, cyclic): 4–8 weeks